Suchergebnisse - "Khiali, Sajad"

PubPharm (17)

1

Current evidence of COVID-19 vaccination-related cardiovascular events

enthalten in: Postgraduate medicine | 2023

von Khiali, S. | Rezagholizadeh, A. | Behzad, H. | +2

2

Tocilizumab in COVID-19 management : addressing time of starting treatment

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Khiali, S. | Entezari-Maleki, T.

3

New Variants of SARS-CoV-2 and Next Generation of COVID-19 Treatments

enthalten in: Journal of clinical pharmacology | 2022

von Khiali, S. | Entezari-Maleki, T.

4

Comprehensive review on molnupiravir in COVID-19 : a novel promising antiviral to combat the pandemic

enthalten in: Future microbiology | 2022

von Khiali, S. | Khani, E. | B Rouy, S. | +1

5

Investigational antiviral drugs for the treatment of COVID-19 patients

enthalten in: Archives of virology | 2022

von Beheshtirouy, S. | Khani, E. | Khiali, S. | +1

6

SARS-CoV-2 and probable lung cancer risk

enthalten in: BioImpacts : BI | 2022

von Khiali, S. | Rezagholizadeh, A. | Entezari-Maleki, T.

7

New Variants of SARS‐CoV‐2 and Next Generation of COVID‐19 Treatments

enthalten in: The Journal of Clinical Pharmacology | 2022

von Khiali, S. | Entezari‐Maleki, T.

8

Potential pharmacologic treatments for COVID-19 smell and taste loss : A comprehensive review

enthalten in: European journal of pharmacology | 2021

von Khani, E. | Khiali, S. | Beheshtirouy, S. | +1

9

Therapeutic Application of Corticosteroids in COVID-19 : A Focus on Optimum Dose and Duration of Therapy

enthalten in: Journal of clinical pharmacology | 2021

von Khiali, S. | Entezari-Maleki, T.

CommentOn: BMC Infect Dis. 2021 Apr 10;21(1):337. - PMID 33838657

10

A comprehensive review on sarilumab in COVID-19

enthalten in: Expert opinion on biological therapy | 2021

von Khiali, S. | Rezagholizadeh, A. | Entezari-Maleki, T.